March 16, 2021 | Compliance Do Two Recent Drug GMP Warning Letters Signal A Shift In FDA Enforcement Focus? Barbara Unger Principal Consultant 7 Minute Read
February 23, 2021 | Compliance Top 10 Most-Cited MHRA GMP Inspection Deficiencies By Annex/Chapter In 2019 – MHRA GMP 2019 Part Two Barbara Unger Principal Consultant 15 Minute Read
February 9, 2021 | Compliance An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report – Part 1 Barbara Unger Principal Consultant 10 Minute Read
May 7, 2020 | Compliance Avoiding and Reacting to Human Tissue, Cell and Gene Therapy Enforcement: Communication is Key Jerry Chapman Senior GMP Quality Expert, Govzilla 4 Minute Read
October 25, 2019 | Compliance SPF Labeled Products are Drugs in the USA. Is Your Company Compliant Under FDA Regulations? Barbara Unger Principal Consultant 2 Minute Read
June 16, 2019 | Compliance EU MDR Applicable to Drug Delivery Systems Janet Whipple Partner 1 Minute Read
February 16, 2019 | Compliance Outsourcing GxP Audits – Mindful Execution is Key to Success Barbara Unger Principal Consultant 4 Minute Read
December 16, 2018 | Compliance EU MDR/IVDR Compliance: A Road Map for Success Janet Whipple Partner 1 Minute Read
February 15, 2018 | Compliance Closing the Gaps: Next Steps in EU MDR Compliance Brian Burns CEO, Validant 3 Minute Read
February 5, 2018 | Compliance Gap Assessments: A Vital First Step to Comply with New EU Medical Device Regulations Brian Burns CEO, Validant 2 Minute Read